Incidence of Meningococcal Disease Before and After Implementation of Quadrivalent Meningococcal Conjugate Vaccine in the United States

IMPORTANCE: In 2005, the US Advisory Committee on Immunization Practices recommended routine quadrivalent meningococcal conjugate (MenACWY) vaccine for all adolescents aged 11 to 12 years, and in 2010, a booster dose for adolescents aged 16 years. Measuring the association between MenACWY vaccinatio...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Pediatr
Autori principali: Mbaeyi, Sarah, Pondo, Tracy, Blain, Amy, Yankey, David, Potts, Caelin, Cohn, Amanda, Hariri, Susan, Shang, Nong, MacNeil, Jessica R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7372499/
https://ncbi.nlm.nih.gov/pubmed/32687590
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapediatrics.2020.1990
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi